Ceftriaxone sodium is a sterile, semisynthetic, broad spectrum cephalosporin antibiotic. Tazobactam sodium is a penicillinic acid sulfone Beta-lactamase inhibitor with a structure similar to that of sulbactam & clavulanic acid. It inactivates susceptible Beta-lactmase by irreversibly binding to the catalytic region of the enzyme. The combination of Tazobactam and ceftriaxone sodium is active against all the organisms resistant to Ceftriaxone.

COMPOSITION
Each vial contains sterile Ceftriaxone Sodium IP equivalent to Ceftriaxone Anhydrous 1000mg tazobactam Sodium equivalent to Tazobactam USP 125mg and 10 ml Water for Injection IP for IV injection.

DOSAGE FORM
Powder for reconstitution (intravenous (I.V)/intramuscular (I.M).

INDICATIONS
To reduce the development of drug-resistant bacteria and maintain the effectiveness of MAYCEFI TZ Injection, it should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.

MAYCEFI TZ Injection is Mainly indicated in the Following Conditions :
Lower respiratory tract infections and community-acquired pneumonia, acute bacterial otitis media, Skin and skin structure infections, Urinary tract infections, Uncomplicated gonorrhea, Pelvic inflammatory disease, Bacterial septicemia, Bone and joint infections, Intra-abdominal infections, Bacterial meningitis, Pre-operative prophylaxis of infections associated with surgery